Written procedures are not established for critical laboratory tasks.
Inspection Record
Clongen Laboratories, LLC — FDA 483 Findings
Inspectors Kevin Matthews · Carl PerezThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
A quality agreement defining the roles and responsibilities of each involved party is not established.
Quality oversight is inadequate.
Equipment is not qualified or monitored for its intended use.
Quality control documentation and practices are inadequate.
Employee training and qualification is inadequate.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-30. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.